Latest Insider Transactions at Catalyst Pharmaceuticals, Inc. (CPRX)
This section provides a real-time view of insider transactions for Catalyst Pharmaceuticals, Inc. (CPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CATALYST PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CATALYST PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2023
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
58,333
+1.45%
|
-
|
|
Feb 15
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,718
-5.1%
|
-
|
|
Feb 15
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,166
+17.33%
|
-
|
|
Feb 15
2023
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
-
|
|
Feb 15
2023
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+0.64%
|
-
|
|
Feb 15
2023
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,666
+2.27%
|
-
|
|
Feb 15
2023
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,024
-36.15%
|
-
|
|
Feb 15
2023
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+50.0%
|
-
|
|
Feb 15
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,353
-1.68%
|
-
|
|
Feb 15
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,666
+6.44%
|
-
|
|
Jan 24
2023
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+13.19%
|
$0
$0.79 P/Share
|
|
Jan 24
2023
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.5%
|
$0
$0.79 P/Share
|
|
Dec 29
2022
|
Patrick J Mcenany Director |
SELL
Bona fide gift
|
Direct |
10,000
-0.26%
|
-
|
|
Dec 28
2022
|
Patrick J Mcenany Director |
SELL
Bona fide gift
|
Direct |
10,000
-0.26%
|
-
|
|
Dec 06
2022
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.43%
|
-
|
|
Dec 06
2022
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.24%
|
-
|
|
Dec 06
2022
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.37%
|
-
|
|
Dec 06
2022
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,133
-0.31%
|
-
|
|
Dec 06
2022
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,834
+0.78%
|
-
|
|
Dec 06
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
5,918
-16.12%
|
$94,688
$16.85 P/Share
|
|
Dec 06
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+28.54%
|
-
|
|
Dec 06
2022
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+25.83%
|
-
|
|
Dec 06
2022
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+10.09%
|
-
|
|
Dec 06
2022
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.48%
|
-
|
|
Dec 06
2022
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+1.4%
|
-
|
|
Dec 06
2022
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.88%
|
-
|
|
Nov 23
2022
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
9,999
-6.27%
|
$169,983
$17.45 P/Share
|
|
Nov 23
2022
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-3.49%
|
$340,000
$17.34 P/Share
|
|
Nov 22
2022
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
20,001
-11.14%
|
$340,017
$17.3 P/Share
|
|
Nov 22
2022
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
120,000
-81.39%
|
$1,920,000
$16.53 P/Share
|
|
Nov 21
2022
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
70,000
-28.05%
|
$1,050,000
$15.23 P/Share
|
|
Nov 21
2022
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
80,000
-12.24%
|
$1,200,000
$15.28 P/Share
|
|
Nov 21
2022
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
150,000
-3.7%
|
$2,250,000
$15.33 P/Share
|
|
Nov 21
2022
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+3.57%
|
$300,000
$2.24 P/Share
|
|
Nov 18
2022
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
350,000
-8.23%
|
$5,250,000
$15.62 P/Share
|
|
Nov 18
2022
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
350,000
+7.6%
|
$700,000
$2.24 P/Share
|
|
Nov 15
2022
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
60,000
-28.92%
|
$900,000
$15.77 P/Share
|
|
Nov 15
2022
|
Charles B O'Keeffe Director |
BUY
Open market or private sale
|
Direct |
87,985
+13.47%
|
$1,407,760
$16.04 P/Share
|
|
Nov 14
2022
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105,000
+35.85%
|
$105,000
$1.32 P/Share
|
|
Nov 11
2022
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
139,017
-100.0%
|
$2,085,255
$15.85 P/Share
|
|
Nov 11
2022
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
139,017
+50.0%
|
$278,034
$2.55 P/Share
|
|
Nov 11
2022
|
Donald A Denkhaus Director |
SELL
Open market or private sale
|
Direct |
20,000
-6.72%
|
$320,000
$16.59 P/Share
|
|
Nov 11
2022
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Open market or private sale
|
Direct |
14,666
-56.93%
|
$234,656
$16.23 P/Share
|
|
Nov 11
2022
|
Preethi Sundaram Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
56,786
-75.0%
|
$908,576
$16.38 P/Share
|
|
Nov 11
2022
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,786
+50.0%
|
$283,930
$5.49 P/Share
|
|
Sep 23
2022
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
60,000
-22.43%
|
$660,000
$11.9 P/Share
|
|
Sep 16
2022
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
90,000
-25.18%
|
$1,170,000
$13.5 P/Share
|
|
Sep 15
2022
|
Preethi Sundaram Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
18,214
-100.0%
|
$254,996
$14.49 P/Share
|
|
Sep 15
2022
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,214
+50.0%
|
$91,070
$5.49 P/Share
|
|
Sep 14
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
143,000
-75.67%
|
$2,145,000
$15.67 P/Share
|